Kosmix
One sec... we're building your guide for
Alemtuzumab
Alemtuzumab
Overview
Before Use
Proper Use
Side Effects
Reference
News & Blogs
Patient Experiences
More
Video
Guides & Articles
Tools
Health Providers & Organizations
Main ›
Tools
›
WebMD
Health Check: How Well Are You Managing Multiple Sclerosis?
Related in the Kosmos
?
Antineoplastic drugs
(11)
Fludarabine
Bevacizumab
Rituximab
Catumaxomab
Busulfan
Busulfan
Augmerosen
Sorafenib
Cyclophosphamide
Chlorambucil
Trastuzumab
Doxorubicin
more...
Monoclonal antibodies
(186)
Adalimumab
Afelimomab
Aflibercept
Afutuzumab
Alacizumab pegol
Alacizumab pegol
Apolizumab
Aselizumab
Atlizumab
Bivatuzumab mertansine
Cantuzumab mertansine
Cedelizumab
Certolizumab pegol
Citatuzumab bogatox
Erlizumab
Etaracizumab
Farletuzumab
Felvizumab
Fontolizumab
Humanized
Inotuzumab ozogamicin
Lebrilizumab
Mepolizumab
Milatuzumab
Ocrelizumab
Ofatumumab
Oportuzumab monatox
Pascolizumab
Pexelizumab
Reslizumab
Rovelizumab
Ruplizumab
Sibrotuzumab
Siplizumab
Solanezumab
Tacatuzumab tetraxetan
Tadocizumab
Talizumab
Tefibazumab
Teplizumab
Tigatuzumab
Toralizumab
Tucotuzumab celmoleukin
Tysabri
Urtoxazumab
Vedolizumab
Visilizumab
3F8
Abagovomab
Abatacept
Abciximab
Abzyme
Adecatumumab
Altumomab
Anatumomab mafenatox
Atorolimumab
Bapineuzumab
Basiliximab
Bavituximab
Bectumomab
Belatacept
Belimumab
Bertilimumab
Besilesomab
Bevacizumab
Biciromab
Bispecific monoclonal antibody
Blinatumomab
Brentuximab vedotin
Cambridge Antibody Technology
Canakinumab
Catumaxomab
Cetuximab
Cixutumumab
Clenoliximab
Conatumumab
Dacetuzumab
Daclizumab
Denosumab
Detumomab
Dorlixizumab
Ecromeximab
Eculizumab
Edobacomab
Edrecolomab
Efalizumab
Efungumab
Elotuzumab
Elsilimomab
Epratuzumab
Ertumaxomab
Etanercept
Exbivirumab
Faralimomab
Figitumumab
Foravirumab
Fresolimumab
Galiximab
Gantenerumab
Gavilimomab
Gemtuzumab ozogamicin
Golimumab
Gomiliximab
HuMax
Ibalizumab
Ibritumomab tiuxetan
Igovomab
Imciromab
Indium (111In) capromab pendetide
Indium (111In) satumomab pendetide
Infliximab
Inolimomab
Ipilimumab
Iratumumab
Keliximab
Labetuzumab
Lemalesomab
Lerdelimumab
Lexatumumab
Libivirumab
Lintuzumab
List of monoclonal antibodies
Lucatumumab
Lumiliximab
Mapatumumab
Maslimomab
Matuzumab
Metelimumab
Minretumomab
Mitumomab
Morolimumab
Motavizumab
Nacolomab tafenatox
Naptumomab estafenatox
Nebacumab
Necitumumab
Nerelimomab
Nimotuzumab
Nomenclature of monoclonal antibodies
Odulimomab
Omalizumab
Oregovomab
Otelixizumab
PRO 140
Pagibaximab
Palivizumab
Panitumumab
Panobacumab
Pemtumomab
Personalized medicine
Pertuzumab
Priliximab
Pritumumab
Rafivirumab
Ramucirumab
Ranibizumab
Raxibacumab
Regavirumab
Rilonacept
Rituximab
Robatumumab
Sevirumab
Siltuximab
Stamulumab
TGN1412
Tanezumab
Taplitumomab paptox
Technetium (99mTc) arcitumomab
Technetium (99mTc) fanolesomab
Technetium (99mTc) nofetumomab merpentan
Technetium (99mTc) pintumomab
Technetium (99mTc) sulesomab
Technetium (99mTc) votumumab
Telimomab aritox
Tenatumomab
Teneliximab
Trastuzumab
Tremelimumab
Tuvirumab
Ustekinumab
Vapaliximab
Veltuzumab
Vepalimomab
Volociximab
Zalutumumab
Zanolimumab
Zolimomab aritox
more...
Antineoplastic and immunomodulating drugs
Chemotherapeutic agents
Immunosuppressants
Antineoplastic drugs
Immunostimulants
Immunosuppressive agents
Immune system
Immunosuppressive
Anti-thymocyte globulin
Antigen
Immunosuppressants
Monoclonal antibody
Humanized
Immunology
Allogeneic
Monoclonal antibody
Immunosuppressive
Humanized
Anti-thymocyte globulin
Leukemia
(36)
CD33
CD52
Chronic lymphocytic leukemia
Tositumomab
Accelerated phase chronic myelogenous leukemia
Accelerated phase chronic myelogenous leukemia
Acute basophilic leukemia
Acute eosinophilic leukemia
Acute erythroid leukemia
Acute lymphoblastic leukemia
Acute monocytic leukemia
Acute myeloblastic leukemia with maturation
Acute myeloid dendritic cell leukemia
Acute myeloid leukemia
Antileukemic drug
B-cell leukemia
B-cell prolymphocytic leukemia
Chronic myelogenous leukemia
Chronic myelomonocytic leukemia
Chronic neutrophilic leukemia
Gemtuzumab ozogamicin
Hairy cell leukemia
Ibritumomab tiuxetan
Juvenile myelomonocytic leukemia
Large granular lymphocytic leukemia
Lymphoid leukemia
Minimal residual disease
Minimally differentiated acute myeloblastic leukemia
Monocytic leukemia
Myeloid leukemia
Myelomonocyte
Plasma cell leukemia
Precursor B acute lymphoblastic leukemia/lymphoma
Prolymphocytic leukemia
Rituximab
T-cell leukemia
T-cell prolymphocytic leukemia
more...
Biotechnology companies
Genzyme
Bayer HealthCare Pharmaceuticals
Genmab
ATC codes
Anatomical Therapeutic Chemical Classification System
ATC code L04
ATC code L01
Tyrosine kinase inhibitors
(15)
Axitinib
Lestaurtinib
Vandetanib
Bosutinib
Cediranib
Cediranib
Dasatinib
Erlotinib
Gefitinib
Imatinib
Lapatinib
Nilotinib
Semaxanib
Sunitinib
Toceranib
Vatalanib
more...
Immunosuppressants
(33)
Abetimus
Tacrolimus
Abatacept
Adalimumab
Afelimomab
Afelimomab
Alefacept
Anakinra
Anti-thymocyte globulin
Atlizumab
Azathioprine
Basiliximab
Certolizumab pegol
Cyclosporine
Daclizumab
Eculizumab
Efalizumab
Etanercept
Everolimus
Gusperimus
Infliximab
Leflunomide
Lenalidomide
Mepolizumab
Methotrexate
Muromonab-CD3
Mycophenolate mofetil
Mycophenolic acid
ReciGen
Rilonacept
Sirolimus
Thalidomide
Tysabri
Ustekinumab
more...
See also
(20)
Drugs
Interferon beta 1a
Relapsing
Remitting
RTK class III
RTK class III
Speedcubing
Expanded Disability Status Scale
Multiple sclerosis
Elmira District Secondary School
Antineoplastic
Chemical substances
Sontuzumab
Yttrium (Y 90) clivatuzumab tetraxetan
Bayer Schering Pharma
Myelin sheath
Herman Waldmann
Renal transplantation
Cytopenias
Cyclosporine
P-values
more...
more categories...
Health Providers & Organizations
›
Vitals.com
